Hudson Event Spotlights Lab-Leak Evidence Amid Fresh DNI Disclosures on U.S.-Funded Biolabs

On June 15, 2026, the Hudson Institute hosted physician-scientist Dr. Steven Quay for the launch of his book 'The Code as Witness: How the COVID Genome Reveals Its Lab Origins and How to Prevent Future Outbreaks.' The event, opened by Sen. Roger Marshall (R-Kan.) and featuring national security expert David Asher, presented genetic markers—including the furin cleavage site, ACE2 receptor optimization, ORF8 features, restriction enzyme patterns, and the D614G mutation—as evidence favoring laboratory manipulation over natural zoonosis. Quay, a Hudson senior fellow, argued these elements align with gain-of-function research practices and called for accountability, biosafety reforms, and curbs on unregulated pathogen work globally. The discussion highlighted persistent institutional reluctance to reach a unified U.S. government consensus on origins, despite years of debate.

Outgoing Director of National Intelligence Tulsi Gabbard’s recent declassification of internal slides documenting U.S. funding for over 120 biological research facilities across more than 30 countries, including dozens in Ukraine, added timely context. The materials, released around June 13, 2026, detail connections involving U.S. agencies, universities, and contractors handling high-risk pathogens, reviving questions about oversight of dual-use research.

Public opinion reflects deepening divides: earlier YouGov polling showed strong Republican belief in a Chinese lab origin (around 85%) versus more modest Democratic support (around 53%), with further splits on intent. Quay and Asher emphasized the absence of a formal COVID commission to clarify provenance, responsibility, and lessons for preventing deadlier future outbreaks. These threads connect suppressed early debate on origins with broader institutional gaps in biosecurity governance.